Letter to the editor

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 4, 2012, Pages 471-472

  Montagnese, Sara ^a   Amodio, Piero ^a   Angeli, Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; ASPARTIC ACID; LACTULOSE; ORNITHINE; PREBIOTIC AGENT; PROBIOTIC AGENT; DIPEPTIDE;

AMMONIA BLOOD LEVEL; BACTERIAL GROWTH; BACTERIAL PERITONITIS; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; COLONY FORMING UNIT; CONTROLLED CLINICAL TRIAL (TOPIC); HEPATIC ENCEPHALOPATHY; HUMAN; INTESTINE MUCOSA; LETTER; LIVER CIRRHOSIS; MICROFLORA; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; FEMALE; MALE; NOTE;

DIPEPTIDES; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LACTULOSE; MALE; PROBIOTICS;

EID: 84859314628     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328351048e     Document Type: Letter

References (9)

1. Mittal VV, Sharma BC, Sharma P, Sarin SK. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalophathy. Eur J Gastroenterol Hepatol 2011; 33:725-732.
2. Shukla S, Shukla A, Mehboob S, Guha S. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy. Aliment Pharmacol Ther 2011; 33:662-671.
3. McGee RG, Bakens A, Wiley K, Riordan SM, Webster AC. Probiotics for patients with hepatic encephalopathy. Cochrane Database Syst Rev 2011; 11:CD008716.
4. Wiest R, Chen F, Cadelina G, Groszmann RJ, Garcia-Tsao G. Effect of lactobacillus-fermented diets on bacterial translocation and intestinal flora in experimental prehepatic portal hypertension. Dig Dis Sci 2003; 48:1136-1141. (Pubitemid 36667839)
5. Bauer TM, Ernandez F, Navasa M, Rodes J. Failure of lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis. J Hepatol 2002; 36:501-506. (Pubitemid 34407338)
6. Chiva M, Soriano G, Rochat I, Peralta C, Rochat F, Llovet T, et al. Effect of lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis. J Hepatol 2002; 37:456-462.
7. De Santis A, Famularo G, De Simone C. Probiotics for the hemodynamic alterations in patients with cirrhosis. Am J Gastroenterol 2000; 95:323-324.
8. Tandon P, Moncrief K, Madsen K, Arrieta MC, Owen RJ, Bain VG, et al. Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study. Iver Int 2009; 29:1110-1115.
9. Salminen SJ, Gueimonde M, Isolauri E. Probiotics that modify disease risk. J Nutr 2005; 135:1294-1298. (Pubitemid 40638351)